YAP1 and hepatocellular carcinoma: Moreover, inhibiting the YAP1, reported as an independent prognostic marker and associated with the disease-free survival HCC patients (Xu et al., 2009), restores hepatocyte differentiation, and reduces the tumor development and the advancement of HCC (Fitamant et al., 2015).